Dr. Gregory Crovetti, MD

NPI: 1750311999
Total Payments
$597,874
2024 Payments
$27,832
Companies
5
Transactions
354
Medicare Patients
886
Medicare Billing
$126,331

Payment Breakdown by Category

Consulting$597,507 (99.9%)
Food & Beverage$367.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $597,507 332 99.9%
Food and Beverage $367.00 22 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $597,507 332 $0 (2024)
Bioventus LLC $297.69 17 $0 (2022)
FIDIA PHARMA USA INC. $29.36 2 $0 (2018)
Lilly USA, LLC $24.06 2 $0 (2017)
DePuy Synthes Sales Inc. $15.89 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $27,832 42 ABBVIE INC. ($27,832)
2023 $33,890 39 AbbVie Inc. ($33,890)
2022 $33,490 24 ABBVIE INC. ($33,473)
2021 $121,069 50 AbbVie Inc. ($121,001)
2020 $81,745 44 AbbVie Inc. ($81,692)
2019 $93,079 55 AbbVie, Inc. ($92,931)
2018 $78,604 45 AbbVie, Inc. ($78,592)
2017 $128,165 55 AbbVie, Inc. ($128,096)

All Payment Transactions

354 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/30/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $327.44 General
12/23/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $327.44 General
12/16/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
12/09/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
11/18/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
11/04/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
10/28/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
10/21/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
10/14/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
10/07/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
09/30/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
09/23/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
09/16/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
09/09/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
09/02/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
08/19/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
08/12/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $327.44 General
08/05/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
07/29/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
07/22/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
07/15/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
07/08/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
07/01/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General
06/17/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,309.76 General
06/10/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $654.88 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 20 20 $6,600 $929.74
2022 4 80 193 $44,733 $5,136
2021 8 352 18,653 $353,091 $61,015
2020 10 434 12,476 $360,591 $59,251
Total Patients
886
Total Services
31,342
Medicare Billing
$126,331
Procedure Codes
23

All Medicare Procedures & Services

23 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 20 $6,600 $929.74 14.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 37 39 $12,207 $2,283 18.7%
20610 Aspiration and/or injection of fluid from large joint Office 2022 16 29 $23,865 $1,517 6.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 15 17 $7,905 $1,268 16.0%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 12 108 $756.00 $67.44 8.9%
J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg Office 2021 18 17,304 $86,520 $28,925 33.4%
20610 Aspiration and/or injection of large joint or joint capsule Office 2021 65 197 $154,997 $11,302 7.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 63 96 $41,760 $8,537 20.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 70 113 $33,335 $7,535 22.6%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 38 38 $16,340 $2,700 16.5%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2021 73 872 $6,104 $759.76 12.4%
73562 X-ray of knee, 3 views Office 2021 12 18 $6,325 $655.77 10.4%
20553 Injections of trigger points in 3 or more muscles Office 2021 13 15 $7,710 $599.59 7.8%
J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg Office 2020 15 10,920 $43,680 $17,581 40.2%
20610 Aspiration and/or injection of large joint or joint capsule Office 2020 74 204 $149,298 $11,655 7.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 72 106 $44,215 $8,375 18.9%
J7321 Hyaluronan or derivative, hyalgan or supartz, for intra-articular injection, per dose Office 2020 12 121 $37,873 $7,515 19.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 83 113 $31,753 $5,854 18.4%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 54 54 $21,978 $3,903 17.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 17 17 $10,336 $2,031 19.7%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2020 83 900 $6,300 $936.61 14.9%
20553 Injections of trigger points in 3 or more muscles Office 2020 13 20 $9,740 $935.48 9.6%
73562 X-ray of knee, 3 views Office 2020 11 21 $5,418 $466.01 8.6%

About Dr. Gregory Crovetti, MD

Dr. Gregory Crovetti, MD is a Internal Medicine healthcare provider based in Mount Pleasant, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750311999.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Crovetti, MD has received a total of $597,874 in payments from pharmaceutical and medical device companies, with $27,832 received in 2024. These payments were reported across 354 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($597,507).

As a Medicare-enrolled provider, Crovetti has provided services to 886 Medicare beneficiaries, totaling 31,342 services with total Medicare billing of $126,331. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Emergency Medicine, Sports Medicine
  • Location Mount Pleasant, WI
  • Active Since 07/04/2006
  • Last Updated 12/20/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1750311999

Products in Payments

  • GELSYN 3 (Device) $185.86
  • GELSYN-3 (Device) $84.88
  • Exogen (Device) $26.95
  • FORTEO (Drug) $24.06
  • HYMOVIS (Device) $17.35
  • MONOVISC (Device) $15.89
  • Hymovis (Device) $12.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Mount Pleasant